IPO Plus

₹130

▲ +1.04 +0.81%

As of 05 Nov 2026 · delayed

NSE Listed

ST-ASM · ASM 1
What does ST-ASM · ASM 1 mean?
NSE · Short Term Additional Surveillance Measure (ASM 1)ST-ASM catches short bursts: a beta-adjusted close-to-close move beyond ±25% in 5 trading days (or ±40% in 15) combined with concentrated trading — or a 75%+ monthly range with fewer than 100–200 unique traders. Practical meaning: margins jump to 50–100% for a few weeks to cool a spike; it either lapses quickly or escalates into LT-ASM if the move sustains.Criteria: Short-term (5 / 15 / 30-day) price-volume abnormality — high-low and close-to-close price variation over the window. Adds 100% margin and a 5% (then 2%) price band.Exchange notice · 2026-11-04

Sotac Pharmaceuticals Ltd. (SOTAC)

Volume: 6,000Avg Vol 1W: 3,360Avg Vol 1M: 1,26052W Range:₹86₹139.65
NSE BSE www.sotacpharma.com AI Report
Key Ratios
Checked 9h ago
Market Cap₹144 Cr
Current Price₹130
Previous Close₹128.96
High / Low (52w)₹139.65 / ₹86
Volume6,000
Avg Vol (1W)3,360
Avg Vol (1M)1,260
Stock P/E25.39
Book Value₹53.28
Dividend Yield15%
ROE9.79%
ROA360.1%
Revenue (TTM)₹102 Cr
Revenue Growth-6.6%
Profit Margin424.7%
Total Debt₹14 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹5.12
P/B2.44
Debt / Equity0.73
50 DMA₹94.27
200 DMA₹106.47
Day change+0.81%
SurveillanceST-ASM · ASM 1
Price Chart
₹130▲ 0.78% · 1Y
₹140₹871.9L
2025-11-07
2026-11-05

20-day avg volume: 1K shares

Pros
  • Pays a dividend yield of 15.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 41% YoY.
Quarterly Results
MetricSept 2022Dec 2022Mar 2023Jun 2023Sept 2023Dec 2023Mar 2024Jun 2024
Revenue₹40 Cr₹20 Cr₹18 Cr₹25 Cr₹27 Cr₹26 Cr₹26 Cr₹25 Cr
EBITDA₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹3 Cr₹1 Cr₹2 Cr
Net Profit₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricJun 2023Sept 2023Dec 2023Mar 2024Mar 2024Jun 2024Mar 2025Mar 2026
Revenue₹19 Cr₹14 Cr₹18 Cr₹104 Cr₹16 Cr₹13 Cr₹101 Cr₹102 Cr
EBITDA₹2 Cr₹2 Cr₹3 Cr₹6 Cr₹2 Cr₹2 Cr₹14 Cr₹13 Cr
Net Profit₹1 Cr₹2 Cr₹1 Cr₹4 Cr₹1 Cr₹1 Cr₹8 Cr₹6 Cr
EPS———3.9——7.265.22
Balance Sheet
MetricMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹30 Cr₹35 Cr₹74 Cr₹105 Cr₹124 Cr₹133 Cr
Total Liabilities₹26 Cr₹32 Cr₹54 Cr₹56 Cr₹66 Cr₹69 Cr
Equity₹5 Cr₹3 Cr₹20 Cr₹49 Cr₹58 Cr₹65 Cr
Total Debt——————
Cash Flow
MetricMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹0 Cr₹10 Cr₹-14 Cr₹-4 Cr₹19 Cr
Investing₹-12 Cr₹-3 Cr₹-12 Cr₹-20 Cr₹-14 Cr₹-7 Cr
Financing₹11 Cr₹3 Cr₹13 Cr₹29 Cr₹16 Cr₹-10 Cr
Free Cash Flow₹0 Cr₹0 Cr₹10 Cr₹-14 Cr₹-4 Cr₹19 Cr
Shareholding
Promoter 72.85% Institutions 16.79% Public 10.36%
Efficiency & Working Capital
ROCE13.3%
Interest Coverage3.1
Dividend Payout—
Debtor Days119 d
Inventory Days98 d
Payable Days98 d
Cash Conversion Cycle118 d
Working Capital Days216 d
Shareholding Details

As of 2026-09-30

Promoter72.9%
FII16.5%
DII0%
Institutions16.5%
Public10.7%
Promoter Pledge0%
No. of Shareholders230
Shareholding Pattern

Quarterly — figures in %. Latest 9 quarters.

PeriodApr 2023Apr 2023Sept 2023Mar 2024Sept 2024Mar 2025Sept 2025Mar 2026Sept 2026
Promoters72.9%72.9%72.9%72.9%72.9%72.9%72.9%72.9%72.9%
FIIs12.9%12.9%8.5%9%8.9%15.1%16.1%16.8%16.5%
DIIs0%0%0%0%0%0%0%0%0%
Public14.3%14.3%18.6%18.2%18.3%12%11%10.4%10.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%
No. of Shareholders784784255245251243240221230
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Kiran Baldevbhai JotaniaShareholding of Promoter and Promoter Group13.1%14,49,000
Vishalkumar Devrajbhai PatelShareholding of Promoter and Promoter Group13%14,31,500
Dineshkumar Babulal GelotShareholding of Promoter and Promoter Group13%14,31,500
Sharadkumar Dashrathbhai PatelShareholding of Promoter and Promoter Group13%14,31,500
Chetankumar Bachubhai PatelShareholding of Promoter and Promoter Group9.7%10,69,250
Shaileshkumar Vishnuprasad PatelShareholding of Promoter and Promoter Group7.3%8,05,000
Craft Emerging Market Fund Pccn- Elite Capital FundPublic Shareholding7.1%7,87,200
Nav Capital Vcc - Nnav Capital Emerging Star FundPublic Shareholding7.1%7,81,200
Mitul Shaileshkumar PatelShareholding of Promoter and Promoter Group3.3%3,62,250
Minerva Ventures FundPublic Shareholding1.6%1,76,400
Pace Stock Broking Services Npvt LtdPublic Shareholding1.5%1,70,400
Walpar Nutritions LimitedPublic Shareholding1.5%1,64,400
Pinki Sharadkumar PatelShareholding of Promoter and Promoter Group0.2%17,500
Dhara Chetankumar PatelShareholding of Promoter and Promoter Group0.2%17,500
Vasantkumar Devrajbhai PatelShareholding of Promoter and Promoter Group0.2%17,500
Sarojben Dineshkumar GelotShareholding of Promoter and Promoter Group0.2%17,500
Dashrathbhai Ramabhai PatelShareholding of Promoter and Promoter Group0%0
Narmadaben DashrathbhainpatelShareholding of Promoter and Promoter Group0%0
Sanjay Dashrathbhai PatelShareholding of Promoter and Promoter Group0%0
Dipikaben Nileshkumar PatelShareholding of Promoter and Promoter Group0%0
Rekhaben Saileshkumar PatelShareholding of Promoter and Promoter Group0%0
Bhavanaben ManishkumarnpatelShareholding of Promoter and Promoter Group0%0
Aarav Sharadkumar PatelShareholding of Promoter and Promoter Group0%0
Krishna Sharadkumar PatelShareholding of Promoter and Promoter Group0%0
Manubhai Sakalchand PatelShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Sharadkumar Dashrathbhai PatelChairman & Managing Director2025
Dineshkumar Babulal GelotWhole-time Director2025
Vishalkumar Devrajbhai PatelExecutive Director2025
Chetankumar Bachubhai PatelExecutive Director2025
Bhavinkumar Prafulbhai JoshiIndependent Non Exe. Director2025
Ketankumar Arvindbhai ModiIndependent Non Exe. Director2025
Dimpal Dhebarbhai PateIndependent Non Exe. Director2025
Niyati Dipesh ParikhCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10121111
Corporate Actions
TypeDateValueRemark
forthcoming2026-09-23Dividend—
dividend2026-09-23₹0.2 (2%)Final
dividend2025-09-19₹0.1 (1%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500014546
202500002626
2025000112
Company Information
Incorporated2015
ChairmanSharadkumar Dashrathbhai Patel
AuditorKeyur Shah & Co
Investor Email[email protected]
🌐 www.sotacpharma.com ↗

📍 Plot No PF-21 Nr ACME Pharma, Opp Teva Pharma Sanand GIDC-II, Ahmedabad, Gujarat, 382110

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Sona BLW Precision Frgs LimitedSonal Mercantile Ltd.Sona Machinery LimitedSonam LimitedSonata Software Ltd.Sonu Infratech LimitedSavita Oil Technologies Ltd.South Indian BankSouth West Pinnacle Exploration Ltd.SP Apparels LimitedSpandana Sphoorty Financial Ltd.Sun Pharma Advanced Research Company Ltd.All “S” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App